Statistics

Total Visits

Views
Long-Term (52-Week) Results Of a Phase 3, Randomized, Controlled Trial Of Apremilast, An Oral Phosphodiesterase 4 Inhibitor, In Patients With Psoriatic Arthritis and Current Skin Involvement (PALACE 3)6

Select a period of time:

Number of views in the range

Views
Long-Term (52-Week) Results Of a Phase 3, Randomized, Controlled Trial Of Apremilast, An Oral Phosphodiesterase 4 Inhibitor, In Patients With Psoriatic Arthritis and Current Skin Involvement (PALACE 3)4

Views

Views
May 20242
June 20240
July 20240
August 20241
September 20240
October 20241
November 20240
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States3
United Kingdom1
 

Top cities views

Views
DeKalb1